Diari digital de la URV -

Show all news from "Department of Biochemistry and Biotechnology"

Jennifer Masip will present the paper at the Conference on Retroviruses and Opportunistic Infections, which brings together more than 4000 leading researchers in HIV from almost 90 countries. Ms Masip is a member of the Infection and Immunity Research Group of the Joan XXIII University Hospital in Tarragona, the Pere Virgili Health Research Institute and the Universitat Rovira i Virgili.

A study by the URV’s Cheminformatics and Nutrition research group has shown that an anti-inflammatory drug for humans and another for animals inhibit a key enzyme in the replication and transcription of the COVID-19 virus. The results of the work have been validated by the initiative COVIDMoonshot which has carried out in vitro studies and assessed their bioactivity. The results have been published in the “International Journal of Molecular Sciences”

A newly identified “metabolic signature” can evaluate an individual’s adherence and metabolic response to the Mediterranean diet and help predict future risk of developing cardiovascular disease (CVD), according to new research led by Harvard University with collaborators from the Broad Institute and Universitat Rovira i Virgili